ESR1 and breast carcinoma: This study aimed to compare work carried out by others in which the ERα interactome was identified using two different cell lines: MCF-7 (ER+ breast cancer) and HeLa (ER-, cervical carcinoma) in order to identify a pathway-related fingerprint common to both cells lines or individually representing each of them.